Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
Breast cancer is the most commonly diagnosed cancer worldwide. Metal metabolism is pivotal for regulating cell fate and drug sensitivity in breast cancer. Iron and copper are essential metal ions critical for maintaining cellular function. The accumulation of iron and copper ions triggers distinct c...
Saved in:
Main Authors: | Murshid Imam, Jiale Ji, Zhijie Zhang, Shunchao Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1493188/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multifunctional drug delivery nanoparticles for combined chemotherapy/chemodynamic/photothermal therapy against colorectal cancer through synergistic cuproptosis/ferroptosis/apoptosis
by: Xiuzhang Yan, et al.
Published: (2025-02-01) -
Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications
by: Yating Cong, et al.
Published: (2025-01-01) -
GSH/pH-responsive copper-based cascade nanocomplexes inducing immunogenic cell death through cuproptosis/ferroptosis/necroptosis in oral squamous cell carcinoma
by: Yi Sun, et al.
Published: (2025-02-01) -
Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma
by: Yanfang Huang, et al.
Published: (2025-01-01) -
Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity
by: Ziwei Gao, et al.
Published: (2025-01-01)